NEW YORK, June 28, 2017 /PRNewswire/ -- Blink Health,
America's leading prescription drug savings platform, recently
launched a program to help #TreatType2 diabetes by
committing to give away $10 million
worth of diabetes medications. People living with diabetes who
create an account on Blink Health's website or free mobile app,
starting today, will receive a free, one-year supply of the three
most commonly prescribed generic medications for type-2 diabetes:
metformin, glipizide and pioglitazone. The program will also cover
these three medications for existing Blink Health patients who use
them.
To create an account, visit the Blink Health
website: https://www.blinkhealth.com/diabetes.
Diabetes in America
As part of Blink Health's ongoing
commitment to support people who are living with diabetes, the
#TreatType2 program is designed to help the largest
population of people managing this condition. Of the nearly 29
million Americans with diabetes, approximately 95 percent have been
diagnosed with type 2. Tragically, African Americans are 77 percent
more likely to be diagnosed with diabetes than non-Hispanic
Caucasians, according to the US Department of Health & Human
Resources. This $10 million giveaway
represents a potential savings of up to $4,000 per patient, per year, for someone who's
taking all three medications and paying the full retail price out
of pocket, either because they are uninsured or have a
high-deductible insurance plan.
Who is Eligible?
Blink Health will provide the free
medications to everyone until it has committed to spending
$10 million on the
medications. Any patient with a prescription for any or all of
these three medications is eligible to receive medication for free.
There is no cost to join Blink Health, and medication can be picked
up at over 57,000 pharmacies nationwide, including Walmart, CVS,
Rite-Aid, Target, and most independent pharmacies and
grocers. Blink Health helps consumers save on the cost of
generic medications – the most common ones prescribed – by
negotiating low prices directly with manufacturers.
"Overall, diabetes is a growing epidemic that affects 1 in 11
Americans, and Blink Health is committed to doing all it can to
help patients manage this chronic illness," said Geoffrey Chaiken, Co-Founder and CEO of Blink
Health. "We have seen far too many people who are struggling to
afford prescription medication, and we've launched this program to
help address the problem one patient at a time."
Information About Discounted Insulin Available Through Blink
Health
Blink Health is also working on solutions to lower the price of
insulin. Blink Health and Eli Lilly and Company (NYSE: LLY) have
entered into a first-of-its-kind access program to offer a 40
percent discount on Lilly insulins, including Humalog, one of the
most widely prescribed branded insulin medications.
Follow us on Facebook and Twitter.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/blink-health-giving-away-10-million-worth-of-free-diabetes-medications-300480284.html
SOURCE Blink Health